Fisher Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,601
| Closed | -$291K | – | 946 |
|
|
2021
Q2 | $291K | Buy |
6,601
+258
| +4% | +$11.4K | ﹤0.01% | 810 |
|
|
2021
Q1 | $313K | Hold |
6,343
| – | – | ﹤0.01% | 778 |
|
|
2020
Q4 | $267K | Sell |
6,343
-100
| -2% | -$4.21K | ﹤0.01% | 817 |
|
|
2020
Q3 | $295K | Sell |
6,443
-2,686
| -29% | -$123K | ﹤0.01% | 743 |
|
|
2020
Q2 | $458K | Sell |
9,129
-2,992
| -25% | -$150K | ﹤0.01% | 670 |
|
|
2020
Q1 | $623K | Buy |
12,121
+29
| +0.2% | +$1.49K | ﹤0.01% | 596 |
|
|
2019
Q4 | $747K | Hold |
12,092
| – | – | ﹤0.01% | 620 |
|
|
2019
Q3 | $726K | Hold |
12,092
| – | – | ﹤0.01% | 639 |
|
|
2019
Q2 | $1.02M | Sell |
12,092
-197
| -2% | -$16.6K | ﹤0.01% | 602 |
|
|
2019
Q1 | $1.17M | Buy |
12,289
+75
| +0.6% | +$7.17K | ﹤0.01% | 576 |
|
|
2018
Q4 | $865K | Hold |
12,214
| – | – | ﹤0.01% | 605 |
|
|
2018
Q3 | $1.04M | Sell |
12,214
-2,469
| -17% | -$211K | ﹤0.01% | 579 |
|
|
2018
Q2 | $1.7M | Sell |
14,683
-5,014
| -25% | -$581K | ﹤0.01% | 543 |
|
|
2018
Q1 | $1.59M | Buy |
+19,697
| New | +$1.59M | ﹤0.01% | 536 |
|